MORE blood pressure pills recalled over carcinogen fears

MORE blood pressure pills recalled over carcinogen fears: 4th round of losartan pulled from US market as the global drug shortage drags on for almost a YEAR Last summer it emerged drugs made in China and India, and dispatched across the world were contaminated with carcinogens NMBA, NMDA, and NDEA  The scandal was kept under wraps for a year before health officials finally acknowledged the contamination It affected valsartan, irbesartan and losartan, some of the most widely-used blood pressure drugs  More than two million people had been exposed, half of whom were in the US On Thursday, Torrent Pharmaceuticals recalled more losartan

By Mia De Graaf Health Editor For Dailymail.com

Published: 14:15 BST, 19 April 2019 | Updated: 14:15 BST, 19 April 2019

View
comments

A fourth round of blood pressure pills have been recalled over fears they may contain carcinogens. 

The move is part of an ongoing scramble to weed out drugs made in China and India, and dispatched across the world, that were contaminated with NMBA, NMDA, and NDEA - all potential cancer-causing chemicals.

The scandal was kept under wraps for a year before health officials finally acknowledged the contamination - and that more than two million people had been exposed.

Once it broke, it prompted a global shortage of the most commonly used blood pressure drugs - valsartan, irbesartan and losartan - that is still dragging on almost a year

read more from dailymail.....

PREV Is the NHS waiting list even bigger than what they're telling us? Real toll may ... trends now
NEXT In bed with big pharma: Corruption fears as report finds US doctors received ... trends now